US expansion dna Communications recently launched a US health education communications offering, signaling a geographic growth objective. This creates an opportunity to engage as a preferred partner for cross-border campaigns, regulatory communications, and market access messaging as they scale in the US.

Executive leadership Appointment of Niamph Mangan as executive vice president and managing director indicates a focus on leadership depth and strategic growth. This opens doors for collaboration on high-level programs, global accounts, and enterprise-level PR initiatives requiring experienced client stewardship.

Biotech to pharma Their client focus spans early-stage biotechs to top 10 pharmaceutical companies, suggesting opportunities across lifecycle marketing, scientific communications, medical congress support, and product approvals for a wide range of biotech and pharma clients seeking specialized health storytelling.

Meaningful health focus Emphasis on translating science into meaningful, patient-centric messages and campaigns creates a selling point for partnerships around patient education, health education initiatives, and digital content programs that improve stakeholder engagement and outcomes.

Digital and media capabilities Tech usage includes platforms across social, creative design, and content distribution tools, with a presence on Snapchat, Kakao, and RSS feeds. This combined with their health education offering presents opportunities to upsell integrated digital campaigns, influencer or platform-specific programs, and data-driven content activations.